Navigation Links
Reliavac® 100cc medium suction evacuator (green)

ProductsReliavac® 100cc medium suction evacuator (green)
Company Bard Medical
Item Reliavac® 100cc medium suction evacuator (green)
Features 
  • 100cc capacity is easy for patient to carry
  • Bottom emptying port reduces chance of contamination
  • Single-use, sterile
    • Description Reliavac 100cc evacuators offer a more constant suction profile than silicone evacuators. 100cc capacity is easy for patient to carry. Bottom emptying port reduces chance of contamination.
    Info Bard Medical
    Customer Service: (800) 526-4455
    Web site: http://www.bardmedical.com/

    Related medicine products :

    1. Reliavac® 100cc low suction evacuator (blue)
    2. Reliavac® 100cc medium suction kits with silicone round drains, 10 in. hole pattern, with trocar
    3. Reliavac® 100cc low suction evacuator kits with flat drains and Y-connector tubing
    4. Reliavac® 100cc medium suction evacuator kits with flat drains and Y-connector tubing
    5. Reliavac® 400cc kits with flat drain, Y-connector tubing
    6. Reliavac® 400cc kits with siliconized PVC drain, Y-connector tube
    7. Reliavac® 400cc kits with silicone round drain with 10 in. hole pattern, trocar, and Y-connector tubing
    8. Reliavac® 400ccEvacuators & Kits
    9. 100cc silicone evacuator
    10. 100cc silicone evacuator with hubless flat drain and trocar
    11. 100cc Silicone Bulb Evacuator with Round Drain and Trocar
    Measure SpO2 and tcpCO2 with a single sensor.
    The TCM400 is the first and only portable instrument to provide up to six simultaneous measurements of transcutaneous oxygen tension (tcpO2)
    Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2.
    ...versity is the only online source of nationally ac...sts, critical care nurses and other healthcare pro...re available online 24/7, so you can take them at ... and a certificate is issued upon course completio...
    Medicine Products:
    (Date:12/2/2008)...goed for Tuesday, December 2, 2008 at 3 pm CST)--R...edical University of South Carolina in Charleston,...of cancer from exposure to radiation during comput...overstated and that new estimates are several time...e MUSC researchers presented their findings at the...
    (Date:12/2/2008)... UCSF Medical Center ranks No. 1 nat...ents are treated using balloon angioplasty, accord...NCDR). , (Vocus) December...wide for the speed with which heart attack patient... to the National Cardiovascular Data Registry (NCD...
    (Date:12/2/2008)...relationships establish special bonds between part...anent partnerships, and ultimately, the start of f...ers place too much emotional weight on their relat...luate their self-worth solely based on the outcome...chologists term as relationship-contingent self-es...
    (Date:12/2/2008)...c. 2 Breast-Specific Gamma Imaging...imaging technique for the diagnosis of,invasive l...east cancer. BSGI,is a molecular breast imaging t...ue density and discover very early stage cancers. ...etic resonance imaging (MRI), BSGI has the,greate...
    Breaking Medicine News(10 mins):Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2
    ...discovered a way to prevent or disturb the formati...ring a string of benefits from preventing lung inf...ntact lenses.// The discovery, by scientists at th...lar Bioscience and the Technical University of Den...
    ... Insitiute, UK suggests that women on tamoxifen ha...on placebo.// They report on a large scale trial o...050 women aged 36 to 65 years, from the UK, Austra... or placebo for five years. All the women were con...
    ...lood of cancer patients reduces the growth of tumo...r where patients have excess of the trace element ...ity of Texas, through research on Wilson's disease...iomolybdate (TM) that could fight cancer by loweri...
    ...ty researchers, people who suffer from the most co...re more prone to have a lower body mass index than... disorder of unknown origins, but doctors believe ... The condition causes increasingly severe tremors ...
    Other Medicine News:Health News:Bacterial discovery may help CF patients 2
    (Date:12/1/2008)...OLIS, Dec. 1 Roche announced today...ifferences in perceived pain and,discomfort assoc...blood,glucose monitoring systems and lancing devi...dicated that, overall, the ACCU-CHEK Aviva and ACC...ems and the ACCU-CHEK Multiclix, ACCU-CHEK,Softcl...
    (Date:12/1/2008)... MEETING, Pa., Dec. 1 G...ed that dosing of subjects has begun in study MSI-... Phase 1b study of trodusquemine (MSI-1436) in ove...novel therapeutic for the treatment of type 2 diab...rally to regulate insulin and leptin pathways thro...
    (Date:12/1/2008)...O, Dec. 1 Vical Incorpor... of a $1.0 million milestone payment from Merck &a...of a Phase I clinical trial of an investigational ...accine is based on Vical,s DNA gene delivery techn...iptase (hTERT). hTERT is the subject of separate l...
    (Date:11/28/2008)...OLIS, Nov. 28 Eli Lilly ...lemental New Drug Application (sNDA) from,the U.S...R) (duloxetine HCl),for the management of chronic...,the first half of 2009, adding data from a recent...itis pain of the knee. , The decision does ...
    Breaking Medicine Technology:Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Worker ants of the world unite 21 You have nothing to lose but your fertility 5939 1Worker ants of the world unite 21 You have nothing to lose but your fertility 5939 2HMS Presents 4th Annual Heroes of Healthcare Awards 30142 1HMS Presents 4th Annual Heroes of Healthcare Awards 30142 2HMS Presents 4th Annual Heroes of Healthcare Awards 30142 3Compound Tied to Cognitive Deficits in Schizophrenia 30140 1Compound Tied to Cognitive Deficits in Schizophrenia 30140 2Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures 30137 1Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures 30137 2